$2.42
+0.01 (+0.41%)
CCO News30 articles
Cameco Shares Gain on TSX Amid US Holiday, Uranium Outlook Steady
Cameco shares rose C$2.33 to C$146.96 on the TSX Monday, while US trading paused. The company posted Q1 net earnings of C$131 million and reaffirmed its 2026 uranium production forecast.
Cameco Q1 Report: Uranium Prices, Westinghouse Stake in Focus
Cameco reports Q1 results May 5. Shares fell Friday; investors watch uranium pricing, delivery schedules, and Westinghouse stake.
NANO Nuclear Stock Surges 18.5% on Strong Cash Position and First Revenue Milestone
NANO Nuclear Energy (NNE) closed the week up 18.5% at $18.85, driven by a strong balance sheet and anticipation of first revenue from its STS acquisition. The company's liquidity covers 58.4% of its market value.
ClearOne Shares Soar 166% on Cortigent Merger Approval
ClearOne (CLRO) shares jumped 166.3% to $9.80 after shareholder approval of the Cortigent merger, with a $122.5 million deal value.
Santander Hits 52-Week High as Webster Deal Clears Final Hurdle
Santander shares reached a 52-week high after the Fed approved its Webster acquisition. The deal closes Aug. 20, with focus on EPS accretion and cost savings.
T1 Energy Jumps 16% on Clearway Order, Financing Doubts Linger
T1 Energy shares rallied 16.4% following a 641 MW module order from Clearway, but unresolved financing and cost issues keep investors cautious.
NANO Nuclear's Cash Cushion Supports Stock Amid Volatile Week
NANO Nuclear (NNE) ended the week 2.1% higher despite a volatile session, with liquidity covering two-thirds of its market value, providing a strong balance-sheet buffer.
NANO Nuclear's Cash Cushion Fails to Lift Shares Near 52-Week Low
NANO Nuclear (NNE) slipped 4.6% to $15.91, near its 52-week low, even as its cash reserves represent 66.6% of market cap. Peers Oklo and NuScale report earnings this week.
Mangoceuticals Rockets 173% on Nuclear Merger; Existing Holders Left with 4%
Mangoceuticals (MGRX) shares soared 173.5% to $0.8029 after announcing a reverse merger with Nuclea Energy, with existing shareholders retaining only 4% pre-PIPE.
Qantas Sunrise Test Clears Range Hurdle, Premium Strategy Faces Market Test
Qantas (ASX:QAN) Project Sunrise A350-1000ULR test flight meets range target. Premium seating at 41.2% of capacity; stock fell 3% on day.
Archer Aviation (ACHR) Weekly Gains Slip Amid Unclear Halo Contract Details
Archer Aviation (ACHR) closed at $4.77, up 7.4% weekly, but 62% of Monday's spike was erased. The Halo reveal with Anduril lacked pricing and delivery details.
India's Nuclear Push Opens 46 GW to Private Players, NTPC and Adani Lead
India's nuclear roadmap allocates 46 GW to private and public utilities beyond NPCIL, with NTPC and Adani Power targeting 30 GW and 10 GW, respectively.
Zhibao Surges 57% on 3,500 Bitcoin PIPE Deal, Dilution Details Unclear
Zhibao Technology (ZBAO) shares surged 57% to $0.285 after a non-binding PIPE deal involving 3,500 bitcoin, valued at $230.2 million. Key details on pricing and dilution are still missing.
Oklo and X-Energy Surge $930M on Early U.S. Nuclear-AI Strategy
Oklo shares jumped 5.6% in after-hours trading, adding $430M to its market cap, as a $200M U.S. nuclear-AI initiative gains traction. X-Energy also surged, bringing combined gains to $930M.
Highway Holdings Shares Jump on Return to Profit, Acquisition Impact Unclear
Highway Holdings (HIHO) shares surged 19.7% after a return to operating profit and 29.2% revenue growth, though the Regent acquisition's impact makes organic trends hard to gauge.
Ondas Shares Surge as DZYNE Sellers Clear 40 Million-Share Block
Ondas shares spiked on volume that allows DZYNE's former owners to sell a 40 million-share block, possibly clearing a key overhang. The transaction involves up to 85 million shares and a deferred payout.
Alibaba Surges $17B on Apple AI Deal, but Revenue Path Unclear
Alibaba's stock surged 6.2% after China approved Apple Intelligence, integrating Alibaba's Qwen AI into Apple's OS. The $16.7B market cap gain highlights investor optimism, but revenue details remain elusive.
SkinHealth Systems Soars on FDA Clearance, Nasdaq Compliance in Focus
SkinHealth Systems shares surged 50% on heavy volume after FDA clearance for its SkinStylus device, but the rally's main significance lies in the company's effort to regain Nasdaq compliance.
ClearOne Soars 48% on Cortigent Merger Details
ClearOne (CLRO) surged 48% after a SEC filing detailed its merger with Cortigent, with trading volume at 48 times its float. The deal includes a $10-15M financing.
AtkinsRéalis Surges on Turkey Nuclear Review, Market Cap Gains C$683M
AtkinsRéalis shares surged 4.81% as Turkey's preliminary review of CANDU reactors boosted investor sentiment, adding C$683 million in market cap.
Glazer Capital Exits Clearwater Analytics as Take-Private Closes
Glazer Capital has exited its position in Clearwater Analytics after the company was taken private at $24.55 per share, with the deal closing on June 25.
Clearwater Analytics Exits NYSE After $8.4B Buyout
Clearwater Analytics (CWAN) delisted from NYSE after its $8.4 billion take-private by Permira and Warburg Pincus closed. Last trade at $24.56, a penny above the $24.55 cash merger price.
Clearwater Analytics Ends Trading at $24.56, Closing $8.4B Buyout
Clearwater Analytics shares traded their last session at $24.56, just above the $24.55 deal price, completing an $8.4B all-cash buyout by Permira and Warburg Pincus.
Constellation Energy Near 52-Week Low Despite Nuclear License Filing and Walmart Deal
Constellation Energy (CEG) shares dropped 4.2% last week, closing near a 52-week low at $264.02, even as the company filed for nuclear license extensions and secured a Walmart power deal.
Clearwater Analytics Delisted After $8.4B Take-Private, Options Settle for Cash
Clearwater Analytics' $8.4B take-private closed June 25 at $24.55/share, a 47% premium. CWAN delisted from NYSE; options settle for $2,455 cash per contract.
Clearwater Analytics Shares Nudge Above Buyout Price as Deal Nears Close
Clearwater Analytics (CWAN) closed at $24.56, one cent above the $24.55 cash buyout price, after securing all regulatory approvals. The narrow spread signals minimal upside for new investors.
Trump Administration Unveils $17.5B Nuclear Loan Plan to Power AI Boom
The Trump administration announced $17.5 billion in conditional loans to accelerate orders for 10 Westinghouse AP1000 nuclear reactors, aiming to meet surging U.S. electricity demand from AI and data centers.
Pentagon Drives Small Nuclear Reactor Deployment, Outpacing Tech Giants
Valar Atomics' Ward 250 reached criticality outside a national lab, signaling a shift as Pentagon demand accelerates small nuclear deployment with over $2B in Army funding.
Nuclear Power Surge: Constellation Energy Rides AI Data Center Wave
Constellation Energy rallied 8.0% this week after a federal mandate to accelerate grid connections for AI data centers, but the stock remains 33.6% below its peak as the market awaits tangible revenue from the AI power demand narrative.
Oklo Gains After Centrus Deal Eases Nuclear Fuel Supply Worries
Oklo shares rose 4% to $61.17 after a HALEU fuel supply deal with Centrus Energy, easing a key constraint for next-gen reactors. The agreement covers fuel for up to five Aurora powerhouses starting in 2029.